ABSTRACT
OBJECTIVE: This study investigated the attitude of Korean physicians toward women's access to emergency contraceptive pills (ECPs) and the reclassification of ECP to a behind-the-counter (BTC) drug. METHODS: This study involved 946 physicians who had prescribed ECP in South Korea. The written questionnaires were completed by obstetricians and gynecologists, family physicians, internal medicine doctors, and pediatricians. RESULTS: Regarding the barriers limiting women's access to ECP, 24.8% of physicians responded that women lacked information about ECP and 22.5% felt that women were likely to be emotionally burdened by visits to clinics or hospitals to obtain ECP prescriptions. Ninety-two percent of physicians responded that ECP should remain a prescription drug while 6.1% stated preferences for a switch to a BTC drug. Physicians who opposed the switch were concerned about the potential abuse of ECP. In order to prevent ECP abuse, the most important factor to be considered was education on contraception. CONCLUSION: A majority of Korean physicians opposed the reclassification of ECP to a BTC drug owing to their belief in increasing the role of educational initiatives about contraception and contraceptive practices before improving the access to ECP. This study is also of the opinion that contraceptive education for youth and adults in Korea should be more realistic and active, with an emphasis on regular contraception use before reclassification. Furthermore, we believe that efforts are needed to ensure accuracy of information on contraception to facilitate women's access to ECP.
Subject(s)
Adolescent , Adult , Female , Humans , Contraception , Education , Emergencies , Internal Medicine , Korea , Physicians, Family , PrescriptionsABSTRACT
Endometrioid stromal sarcoma (ESS) of ovary is very rare disease. These mesenchymal neoplasms occur most commonly in the uterus and occasionally originate from extra-uterine sites, such as the ovary. It is often associated with endometriosis of the ovary. Here we present this rare case to emphasize on the clinicopathologic features and fertility-sparing surgery outcome of ovarian ESS in patients with endometriosis.
Subject(s)
Female , Humans , Endometriosis , Fertility Preservation , Ovarian Neoplasms , Ovary , Rare Diseases , Sarcoma , UterusABSTRACT
In the binary of gender, women and femininity came to be associated with motherhood, nurturing, and beauty whilst men and masculinity were associated with productivity, protection, and strength. No longer are we to systematically categorize an individual's gender in terms of polar opposite of femininity and masculinity, but instead we must acknowledge all that resides in between those two poles and allow for identity terms that best express their sense of self. The term ‘transgender has become an umbrella term for a broader and more encompassing array of gender narratives outside of the binary norm of gender. Gender dysphoria is managed and treatable through psychotherapy and through the social and medical transition of gender. The support of transgender individuals' preferred gender through social acknowledgment, gender expression, hormone therapy, and surgery has been proven to alleviate symptoms of gender dysphoria in transgender people, enabling them to incorporate back into society.
Subject(s)
Female , Humans , Male , Beauty , Efficiency , Femininity , Gender Dysphoria , Gender Identity , Masculinity , Psychotherapy , Transgender PersonsABSTRACT
This regulatory post-marketing surveillance study aimed to evaluate the therapeutic efficacy and safety of drospirenone (DRSP) 2 mg/estradiol (E₂) 1 mg tablet in Korean postmenopausal women. A total of 4,149 patients were enrolled and the study was conducted at 207 clinical research centers. The patients' source data was collected between November 2006 and November 2012. More than 85% of patients experienced improvement of menopausal symptoms. The most frequently reported adverse events were vaginal bleeding and breast pain; most of the women suffering from these symptoms fully recovered. The incidence of adverse event was higher in patients of younger age (20 to 39 years), in patients with concomitant diseases, previous hormone replacement therapy in medical history, those treated with DRSP 2 mg/E₂ 1 mg for shorter duration (3 years or less) and in patients using concomitant medication. In conclusion, the results from this large post-marketing surveillance study confirm the efficacy and safety of DRSP 2 mg/E₂ 1 mg tablet in Korean postmenopausal women.
Subject(s)
Female , Humans , Hormone Replacement Therapy , Incidence , Mastodynia , Menopause , Uterine HemorrhageABSTRACT
OBJECTIVES: To compare the urodynamic characteristics between pre- and post-menopausal women with stress urinary incontinence. METHODS: Forty premenopausal women and 44 postmenopausal women with stress urinary incontinenece were enrolled. All of the patients underwent a detailed history, gynaecologic examination, urinalysis and urodynamics including cystometry and pressure-flow analysis. RESULTS: There was no difference in the body mass index between the two groups. The mean age of pre- and post-menopausal women was 40.9 +/- 6.4 years and 62.1 +/- 9.4 years, respectively. The parity in postmenopausal women was greater than premenopausal women (2.8 +/- 1.2 vs 2.2 +/- 0.8, P = 0.026). The valsalva leak point pressure (VLPP) in postmenopausal women was lower than that in premenopausal women (106.4 +/- 30.3 vs 88.2 +/- 25.1 cmH2O, P = 0.04). The maximal urethral closure pressure (MUCP) in postmenopausal women was lower than premenopausal women (44.9 +/- 21.4 vs 77.4 +/- 32.2 cmH2O, P < 0.001). The functional urethral length (FUL) in postmenopausal women was shorter than it in premenopausal women (29.0 +/- 9.7 vs 37.0 +/- 10.9 mm, P = 0.003). There were no significant statistical differences in maximal flow rate, residual urine, maximal bladder capacity and Q tip test. CONCLUSION: The VLPP and MUCP were lower, and the FUL was shorter in postmenopausal women with stress urinary incontinence than premenopausal women. The parity and number of vaginal deliveries were different between the two groups. Further investigation will be needed concerning these variables.
Subject(s)
Female , Humans , Body Mass Index , Parity , Postmenopause , Premenopause , Retrospective Studies , Urinalysis , Urinary Bladder , Urinary Incontinence , UrodynamicsABSTRACT
Uterine leiomyoma is common benign tumor in reproductive age woman. And secondary degeneration of uterine leiomyoma can be occurred usually during midpregnancy and the puerperium. But, spontaneous perforation of uterine leiomyoma with cystic degeneration is very rare. We have experienced a case of spontaneous perforation of a huge cystic degenerative uterine leiomyoma associated with massive hemoperitoneum in a menopausal woman, and report it with a brief review of literature.
Subject(s)
Female , Humans , Hemoperitoneum , Leiomyoma , Postpartum PeriodABSTRACT
PURPOSE:The objective of this study was to evaluate the indications, effectiveness and complications associated with uterine arterial embolization as an alternative treatment of obstetrical hemorrhage. METHODS:From January 2006 to December 2008, 25 patients who underwent angiographic embolization for the obstetrical hemorrhage that was not responsive to conventional treatments, like obstetric maneuvers and uterotonic drugs, were included in our study. All medical records were reviewed and detailed clinical data such as clinical status, underlying conditions, amount of transfusion, embolized arteries, hospital stay, the success rate and the complications were collected. RESULTS:We have experienced clinically successful embolization in 22 (88%) of 25 patients with obstetrical hemorrhage resulting from various causes. After embolization, the patients' vital signs were stabilized. The causes of hemorrhage were atony of uterus (n=10), myomectomy during cesarean section (n=6), abnormal placentation (n=5), arterio-venous malformation (n=3), and cervical pregnancy (n=1). The average amount of blood transfusion was 7.2 units (range; 0~39 units). The average length of the time for the procedure was 55 minutes (range: 25~96 minutes). The average duration of hospitalization was 5.5 days (range: 2~14 days). In 22 patients, menses resumed spontaneously after procedures. The main complications after embolization were numbness and pain on lower extremities (n=1), and hypomenorrhea (n=1). CONCLUSION:The atrerial embolization is one of the safe and effective procedures that offers patients an alternative to hysterectomy for the treatment of intractable postpartum hemorrhage.
Subject(s)
Female , Humans , Pregnancy , Arteries , Blood Transfusion , Cesarean Section , Hemorrhage , Hospitalization , Hypesthesia , Hysterectomy , Length of Stay , Lower Extremity , Medical Records , Menstruation Disturbances , Placentation , Postpartum Period , Uterus , Vital SignsABSTRACT
Premature ovarian failure (POF) is defined as the complete cessation of menses less than 40 years of age. The criteria are more than four months of amenorrhea, with serum follicle stimulating hormone value of >40 mIU/mL and the frequency of POF is about 1% of all women. Although the etiologies of POF remain unknown, suggested factors are genetic, autoimmune, chemotherapy, radiotherapy and environmental toxins. The cytogenetic abnormalities predominantly concern the X chromosome, including Turner syndrome, Fragile X syndrome and deletion, translocation, or duplication of X chromosome. We report a very rare case of premature ovarian failure with the following karyotype: 46,X,dup(Xq), and report it with a brief review of literature.